Fenofibrate and Alcohol/Food Interactions
There are 2 alcohol/food/lifestyle interactions with fenofibrate.
Moderate Drug Interaction
Fenofibrate may increase the blood levels and effects of nicotine. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Major Potential Hazard, Moderate plausibility
fibric acid derivatives - HDL cholesterol
There have been reports of severe decreases in HDL cholesterol (HDL-C) levels (as low as 2 mg/dL) occurring in diabetic and non-diabetic patients initiated on fibric acid derivatives therapy. The decrease has been reported to occur within 2 weeks to years after initiation of therapy. It is recommended that HDL-C levels be checked within the first few months after initiation therapy and if a severely depressed HDL-C level is detected, therapy with these agents should be withdrawn. Monitor HDL-C level until it has returned to baseline, and therapy with these agents should not be re-initiated in these patients.
- "Product Information. Lopid (gemfibrozil)." Parke-Davis (2002):
- Thompson CH, Irish A, Kemp GJ, Taylor DJ, Radda GK "Skeletal muscle metabolism before and after gemfibrozil treatment in dialysed patients with chronic renal failure." Clin Nephrol 45 (1996): 386-9
- Gorriz JL, Sancho A, Lopezmartin JM, Alcoy E, Catalan C, Pallardo LM "Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy." Nephron 74 (1996): 437-8
- "Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical (2001):
Fenofibrate drug interactions
There are 136 drug interactions with fenofibrate.
Fenofibrate disease interactions
There are 7 disease interactions with fenofibrate which include:
- biliary cirrhosis
- HDL cholesterol
- liver disease
- renal dysfunction
- hematological changes
More about fenofibrate
- fenofibrate consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (68)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fibric acid derivatives
- En español
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.